OCM
Orion Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Hold |
300
| – | – | 0.01% | 332 |
|
|
2025
Q1 | $10.2K | Sell |
300
-293
| -49% | -$9.97K | ﹤0.01% | 355 |
|
|
2024
Q4 | $23.3K | Buy |
+593
| New | +$23.3K | 0.01% | 298 |
|
|
2024
Q3 | – | Sell |
-843
| Closed | -$45.5K | – | 196 |
|
|
2024
Q2 | $45.5K | Buy |
843
+123
| +17% | +$6.64K | 0.02% | 238 |
|
|
2024
Q1 | $49.1K | Buy |
720
+220
| +44% | +$15K | 0.03% | 239 |
|
|
2023
Q4 | $31.3K | Hold |
500
| – | – | 0.02% | 283 |
|
|
2023
Q3 | $22.7K | Buy |
+500
| New | +$22.7K | 0.01% | 303 |
|
|
2023
Q2 | – | Sell |
-500
| Closed | -$22.6K | – | 194 |
|
|
2023
Q1 | $22.6K | Hold |
500
| – | – | 0.02% | 297 |
|
|
2022
Q4 | $20.3K | Hold |
500
| – | – | 0.01% | 259 |
|
|
2022
Q3 | $33K | Hold |
500
| – | – | 0.03% | 230 |
|
|
2022
Q2 | $30K | Hold |
500
| – | – | 0.02% | 231 |
|
|
2022
Q1 | $31K | Hold |
500
| – | – | 0.02% | 240 |
|
|
2021
Q4 | $38K | Hold |
500
| – | – | 0.02% | 217 |
|
|
2021
Q3 | $56K | Hold |
500
| – | – | 0.03% | 186 |
|
|
2021
Q2 | $81K | Buy |
500
+400
| +400% | +$64.8K | 0.05% | 161 |
|
|
2021
Q1 | $12K | Buy |
+100
| New | +$12K | 0.01% | 239 |
|